| Related Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Disposing of Expired Drugs and Chemicals: New Options for Compounders
Vail Jane
|
Jan/Feb 2008
Pg. 38-47
View Sample |
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
|
Nov/Dec 2011
Pg. 526-527
|
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
|
Jan/Feb 2020
Pg. 30-36
|
PostScription: Consumer Options for Disposal of Unused Medications
Vail Jane
|
Jan/Feb 2008
Pg. 87
|
Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response
Briggs Valerie
|
Sep/Oct 2010
Pg. 366-369
|
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
PreScription: Factors Related to Drug Waste and Pharmacy Solutions
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 268
|
Standard Operating Procedure: Disposal of Chemicals
Allen Loyd V Jr
|
May/Jun 2004
Pg. 210
|
Compounding Pharmacy: A Unique Service for a Unique Population
Williams LaVonn A, Franck Paul
|
Jan/Feb 2010
Pg. 19-20
|
Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021
Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
|
Nov/Dec 2021
Pg. 446-462
|
Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
|
May/Jun 2016
Pg. 202-206
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
|
Nov/Dec 2012
Pg. 456-460
|
The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
|
Jul/Aug 2022
Pg. 298-301
|
Patient-centered Care as Value-added Service by Compounding Pharmacists
McPherson Timothy B, Fontane Patrick E, Day Jonathan R
|
Jul/Aug 2013
Pg. 339-343
|
PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services
Lees Deril J
|
Jan/Feb 2014
Pg. 87
|
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 294-298
|
PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 92
|
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
|
Sep/Oct 2021
Pg. 358-362
|
Allowing Compounding Pharmacies to Address Drug Shortages
Broughel James
|
Mar/Apr 2022
Pg. 100-109
|
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
|
Mar/Apr 2004
Pg. 101-105
|
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Jan/Feb 2008
Pg. 74-82
|
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Stephenson Kenna, Jones William, Stephenson Douglas M M
|
May/Jun 2006
Pg. 175-183
|
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
|
Sep/Oct 2014
Pg. 379-380
|
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
|
Sep/Oct 2015
Pg. 377-380
|
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations
Donnelly Ronald F
|
Sep/Oct 2015
Pg. 383-386
|
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
|
Jan/Feb 2017
Pg. 47-56
|
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 487-488
|
Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients
McElhiney Linda F
|
Jan/Feb 2018
Pg. 30-39
|
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
|
Mar/Apr 2018
Pg. 108-121
|
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")
Allen Loyd V Jr, Ashworth Lisa D
|
Jan/Feb 2005
Pg. 44-46
|
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer
Kramer Mark A, Grilley Bambi J
|
Jul/Aug 2002
Pg. 271-273
|
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 350-351
|
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 389-390
|
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Lopez C Vidal, Rios GL Quito
|
Sep/Oct 2022
Pg. 358-362
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2009
Pg. 56-62
|
Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs
Burke John, Hill Jeff
|
Mar/Apr 2010
Pg. 131-133
|
Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 308-315
|
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja, Krämer Irene, Kamin Wolfgang
|
May/Jun 2013
Pg. 254-261
|
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 446-448
|
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 350-351
|
Standing Together Fixing the Drug Quality and Security Act
Miller David G
|
Mar/Apr 2015
Pg. 104-106
|
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Palma Elisabetta, Bufarini Celestino
|
Sep/Oct 2014
Pg. 358-364
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 396-400
|
Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes
de Wilde Sofieke, Crul Mirjam, Breukels Oscar
|
Mar/Apr 2023
Pg. 154-159
|
Good Enough for America
Worthen Dennis B
|
Jan/Feb 2014
Pg. 20-29
|
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
|
Jul/Aug 2015
Pg. 303-305
|
Documentation: Records and Reports
Akers Michael J
|
Sep/Oct 2017
Pg. 373-380
|
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 44-50
|
Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing
Douglass Kate, Kastango Eric S
|
Mar/Apr 2001
Pg. 140-144
|
Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo.
Allen Loyd V Jr
|
Mar/Apr 2004
Pg. 107-109
|
Ambulatory Care Medicine: Definition and Scope of Service
Wenmark William H
|
Nov/Dec 1997
Pg. 377-378
|
Developing and Providing Compounding Services for Hospitals Involved in a Merger
McElhiney Linda F
|
Jan/Feb 2004
Pg. 36-39
|
PreScription: Drug Shortages and Discontinued Drugs
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 268
|
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
|
Sep/Oct 2021
Pg. 364-371
|
PreScription: Compounded Drugs Often Become Manufactured Drugs
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 444
|
Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients
Moore Renee
|
Sep/Oct 2012
Pg. 394-395
|
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013
Miller David G
|
Jan/Feb 2014
Pg. 35-36
|
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
|
Nov/Dec 2016
Pg. 457-458
|
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
|
May/Jun 2016
Pg. 217-222
|
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Brunner Scott
|
Jul/Aug 2020
Pg. 296-297
|
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Teimouri Arezou, Yeung Pollen, Agu Remigius U
|
Nov/Dec 2020
Pg. 501-508
|
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
|
Jan/Feb 2021
Pg. 52-61
|
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags
Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
|
Jul/Aug 2018
Pg. 345-349
|
How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
|
May/Jun 2019
Pg. 182-186
|
PreScription: Compounding for Drug Shortages
Allen Loyd V Jr
|
May/Jun 2013
Pg. 180
|
Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
|
Jul/Aug 2011
Pg. 302-307
|
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications
Gilbert John A
|
Sep/Oct 2009
Pg. 400-403
|
Compounding OTC Drugs: A Legal Perspective
Gibbs Jeffrey N, Mazan Kate Duffy
|
May/Jun 2000
Pg. 180-181
|
Wish You Were Here: Oklahoma Frontier Drug Store Museum
Worthen Dennis B
|
May/Jun 2000
Pg. 188-189
|
Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 292-293
|
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A, Saenz Christopher
|
Jul/Aug 2002
Pg. 311-315
|
The Compatibility of Common Respiratory Therapy Drug Combinations
Owsley Heather D, Rusho William F
|
Mar/Apr 1997
Pg. 121-122
|
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Vail Jane
|
Jan/Feb 2003
Pg. 21-23
|
Determining the Availability of a Commercial Drug
|
Jan/Feb 2003
Pg. 44-45
|
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
|
Sep/Oct 2007
Pg. 426-432
|
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 438-439
|
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Harrington Catherine A, Cauffield Jacintha
|
May/Jun 2005
Pg. 201-205
|
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 377-379
|
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
|
Jan/Feb 2023
Pg. 22-23
|
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
|
Jul/Aug 2023
Pg. 340-346
|
Drug Utilization Review: Our Patients Deserve Our Very Best
Jackson Kathleen
|
Nov/Dec 2023
Pg. 450-453
|
Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 385-395
|
Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 149-151
|
Drug Products and Drug Packaging for the Elderly
Allen Loyd V Jr
|
May/Jun 1997
Pg. 150-151
|
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs
Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
|
Sep/Oct 2013
Pg. 424-431
|
Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 35-44
|
How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
|
Nov/Dec 2019
Pg. 454-461
|
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
|
Mar/Apr 2014
Pg. 94-99
|
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2
Allen Loyd V
|
Jul/Aug 2015
Pg. 280-287
|
Pharmacogenomics: Precision Pharmacy in 503A Compounding
Drummond Joseph, Bennet Daron, Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 95-107
|
PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 92
|
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
|
Jan/Feb 2019
Pg. 32-33
|
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration
Kupiec Tom, Kemp Jesse
|
Jul/Aug 2007
Pg. 326-327
|
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2008
Pg. 276-278
|
Premarin: The Intriguing History of a Controversial Drug
Vance Dwight A
|
Jul/Aug 2007
Pg. 282-286
|
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding
Anderson Derick
|
Jan/Feb 2007
Pg. 56-58
|
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration
Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2006
Pg. 230-233
|
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding
Chan Debora Schotik
|
Mar/Apr 2001
Pg. 97-100
|
Facilities and Procedures for Compounding Hazardous Drugs
Rahe Hank
|
Jul/Aug 2002
Pg. 267-270
|
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A, Williams Kimberly Y, Baker Ma
|
Jan/Feb 2001
Pg. 69-73
|
The Problem of Drug Diversion
Burke John J
|
Jan/Feb 2002
Pg. 11-12
|
Rapid Pharmacokinetic Evaluation of Topical Drug Formulations
Garzouzi Victoria L, Reifenrath William G
|
Jul/Aug 1999
Pg. 321-324
|
Compounding Using Hazardous Drugs
Lau Kellie
|
Jul/Aug 2000
Pg. 261-263
|
An Excel Spreadsheet for Estimating Sodium-Chloride Equivalents for Drugs
Monnot Chris L
|
Mar/Apr 2004
Pg. 123-125
|
Book Reviews: Veterinary Drug Handbook: Client Information Edition
Reed-Kane Dana
|
May/Jun 2005
Pg. 173
|
Drug Therapy for Acute and Chronic Pain in the Cat
Lascelles B Duncan
|
Sep/Oct 2002
Pg. 338-343
|
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time
Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
|
Sep/Oct 2012
Pg. 431-433
|
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act
Pore R David
|
Nov/Dec 2012
Pg. 446-450
|
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations
Jasti Bhaskara R, Saraf Poonam
|
May/Jun 2011
Pg. 259-261
|
Drug Compatibility and Stability in Dextrose vs Saline
Newton David W
|
May/Jun 2011
Pg. 190-192
|
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Bramwell Bethany L, Williams LaVonn A
|
Jan/Feb 2012
Pg. 62-63
|
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
|
Jan/Feb 2009
Pg. 14-18
|
Canine Public Servants: Caring for Drug Detection Dogs
Davidson Gigi S
|
Sep/Oct 2008
Pg. 384-390
|
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 92
|
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
|
Sep/Oct 2017
Pg. 418-425
|
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
|
Mar/Apr 2017
Pg. 95-102
|
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations
Newton David W
|
Jul/Aug 2019
Pg. 281-287
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing
Riepl Mike
|
Mar/Apr 2021
Pg. 100-103
|
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
|
May/Jun 2014
Pg. 208
|
A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis
Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B
|
Jan/Feb 2016
Pg. 71-80
|
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
|
May/Jun 2022
Pg. 214-217
|
PreScription: Pharmacy and Drug Information
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 268
|
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 474-481
|
PreScription: New Drug Approvals 2022 and Compounding Opportunities
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 4
|
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product
Chauhan Nikita N, Patel Jayvadan K
|
Jan/Feb 2023
Pg. 60-71
|
PreScription: Shortages Continue--Compounding Pharmacies Fill the Gap…Again!
Allen Loyd V Jr
|
May/Jun 2023
Pg. 180
|
Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 400-408
|
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
|
Jan/Feb 2022
Pg. 72-79
|
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding
Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
|
Nov/Dec 2021
Pg. 515-522
|
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
|
Mar/Apr 2021
Pg. 146-155
|
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
|
Mar/Apr 2016
Pg. 148-154
|
PreScription: Déjà Vu All Over Again
Allen Loyd V Jr
|
May/Jun 2014
Pg. 180
|
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance
Miller David G
|
Nov/Dec 2015
Pg. 449-450
|
NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 446-448
|
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk
Cabaleiro Joe
|
Jan/Feb 2020
Pg. 21-27
|
Contamination Control in Compounding Areas
Mulder Kyle, Gonzales Ben A
|
Jul/Aug 2019
Pg. 271-278
|
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George, Daleo Charles, Batson SL
|
Sep/Oct 2019
Pg. 358-364
|
Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
|
Jul/Aug 2017
Pg. 301-308
|
Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 388-392
|
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
|
Sep/Oct 2018
Pg. 401-404
|
Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 294-300
|
Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1
Allen Loyd V Jr
|
May/Jun 2018
Pg. 220-228
|
Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
|
Jan/Feb 2022
Pg. 65-71
|
Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging
Biundo Bruce
|
Jan/Feb 2010
Pg. 26-31
|
Drug Compatibility with a New Generation of VISIV Polyolefin Infusion Solution Containers
Aloumanis Vasileios, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Mar/Apr 2009
Pg. 162-165
|
Compendial Activities Relating to Cold Chain Management Issues: Drug Products and Compounded Preparations
Okeke Claudia C
|
Mar/Apr 2009
Pg. 128-136
|
A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard
Walker Heather, Sridhar Vishak, Alexander Kenneth S
|
Nov/Dec 2011
Pg. 510-514
|
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions
Roy Julie, Brault Julie, Joran Pierre, Metrop Raphael, Hildgen Patrice
|
Sep/Oct 2011
Pg. 428-434
|
Preparation and Evaluation of Sustained Drug Release from Pluronic Polyol Rectal Suppositories
Anderson Derick, Amiji Mansoor M
|
May/Jun 2001
Pg. 234-237
|
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P
|
May/Jun 2002
Pg. 230-233
|
Three Drug Stability Lives
Newton David W
|
May/Jun 2000
Pg. 190-193
|
Electronically Controlled Drug Delivery
Kloesel Lawson
|
Nov/Dec 1999
Pg. 439-440
|
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Goodwin Donald A, Fuhram L Clifton
|
Nov/Dec 1999
Pg. 496-500
|
Drug Stability and Compatibility: Special Considerations for Home Health Care
Lima Hetty A
|
Sep/Oct 1997
Pg. 301-305
|
Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions
Martinez Juan F, Trissel Lawrence A, Gilbert Doward L Jr
|
Sep/Oct 1997
Pg. 356-358
|
TPN Bulk Compounding from Bulk Drug Substances
Chamallas Stanley N
|
Sep/Oct 1998
Pg. 347-349
|
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction.
Trissel Lawrence A, Zhang Yanping
|
May/Jun 2004
Pg. 231-235
|
Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective
Vail Jane
|
Jan/Feb 2002
Pg. 13-15
|
Animal Drug Delivery Systems
Allen Loyd V Jr
|
Jul/Aug 1997
Pg. 229
|
Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane
Tenjarla Srini N, Ward Earl S, Fox Janet L
|
Jan/Feb 1998
Pg. 83-88
|
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration
Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S
|
Jul/Aug 2001
Pg. 314-319
|
Drugs Banned for Use in Food Animals: An Explanation
Davidson Gigi S
|
Mar/Apr 2001
Pg. 101-103
|
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration
Trissel Lawrence A, Gilbert Doward L, Wolkin Allan C
|
May/Jun 1999
Pg. 241-244
|
PostScription: Stopping Drug Reps at the Door
Brewer Benjamin
|
Jan/Feb 2006
Pg. 80
|
Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 50-51
|
Standard Operating Procedure: Inventory--Veterinary Drugs and Supplies
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 450-451
|
Submitting Compelling Case Reports for Drug Therapy in Veterinary Patients
Davidson Gigi S
|
Sep/Oct 2007
Pg. 390-395
|
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin
Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
|
Nov/Dec 2018
Pg. 498-503
|
Trends of Extemporaneous Drug Prescription in Latvia in 2017
Kiselova Olga, Maurina Baiba, Sidlovska Venta, Rogovska Irena
|
May/Jun 2019
Pg. 245-249
|
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
McNulty John P, Muller George
|
May/Jun 2014
Pg. 190-200
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Riepl Mike
|
Jul/Aug 2021
Pg. 282-287
|
Best Practices When Compounding FDA-Approved Drugs Listed in Shortage
Alliance for Pharmacy Compounding
|
Jan/Feb 2025
Pg. 22-27
|
Compounded GLP-1 Drugs and Patient Adverse Events
Alliance for Pharmacy Compounding
|
Jan/Feb 2025
Pg. 33-36
|
Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
|
Mar/Apr 2025
Pg. 121
|
PostScription: Opportunities to Change the Pharmacy Landscape
Menighan Thomas E
|
May/Jun 2015
Pg. 271
|
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Nov/Dec 2006
Pg. 462-468
|
Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care
Fassett William E
|
Nov/Dec 2003
Pg. 441-447
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David G
|
Nov/Dec 2012
Pg. 476-478
|
Compounding for Manufacturer Backorders and Discontinuations: "Oh, No! Not Again!"
McElhiney Linda F
|
Jan/Feb 2009
Pg. 20-25
|
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting
McElhiney Linda F
|
Jul/Aug 2009
Pg. 300-310
|
Basics of Compounding: Basics of Compounding with Organic Salts
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 322-326
|
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W, Trissel Lawrence A
|
Jul/Aug 2004
Pg. 251-263
|
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study
Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
|
May/Jun 2005
Pg. 242-246
|
Pediatric Compounding: Coloring Outside the Lines
Preckshot John
|
Jan/Feb 2001
Pg. 6-8
|
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
Book Reviews
Reed-Kane Dana
|
Jul/Aug 2000
Pg. 288
|
Basics of Compounding: Compounding with Silicones
Allen Loyd V Jr
|
May/Jun 2015
Pg. 223-230
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jul/Aug 2015
Pg. 295-300
|
Basics of Compounding: The "Negative" List
Allen Loyd V
|
Jul/Aug 2015
Pg. 311-313
|
Basics of Compounding: The Revised "Not to Compound List"
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 57-58
|
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Timko Robert J, Crooker Philip EM
|
Mar/Apr 2014
Pg. 101-111
|
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
|
Jul/Aug 2013
Pg. 307-311
|
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
|
May/Jun 2015
Pg. 261-267
|
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations
McCrory Gary
|
Mar/Apr 2016
Pg. 95-96
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016
Pg. 367-374
|
Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 389-396
|
When to Compound Medications for Veterinary Patients
Forsythe Lauren Eichstadt
|
Jan/Feb 2017
Pg. 19-21
|
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 127-130
|
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
|
Mar/Apr 2017
Pg. 164-170
|
Basics of Nonsterile Compounding: Excipients Used in Nonsterile Compounding, Part 5: Compounding Using Solvents and Cosolvent Systems
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 114-118
|
Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia
Sorrieul Jérémy, Robert Julien, Chapel Fanny, Gossye Thomas, Devys Catherine
|
Mar/Apr 2020
Pg. 156-162
|
U.S. Food and Drug Administration Takes Aim (Again) at Animal Compounding: Draft Guidance for Industry #256 Lacks Authority, Will Increase Costs, and Put Pets at Risk
Brunner Scott
|
May/Jun 2020
Pg. 198-199
|
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
McElhiney Linda F
|
Jul/Aug 2020
Pg. 287-295
|
Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review
Milibari Loay, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter
|
Jul/Aug 2020
Pg. 346-351
|
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 31-38
|
Certification of Powder-containment Hoods for Nonsterile Compounding
Mulder Kyle, Dozzi Raphael
|
Sep/Oct 2018
Pg. 369-384
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions
Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei
|
Mar/Apr 2018
Pg. 164-171
|
An Outlook on the European and Italian Rules to Guarantee Magistral Formulas
Selmin Francesca, Casiraghi Antonella, Musazzi Umberto M, Fortini Marco, Minghetti Paola
|
Jan/Feb 2019
Pg. 6-12
|
Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 293-298
|
Feline Transdermal Formulation Considerations
Forsythe Lauren Eichstadt
|
Nov/Dec 2017
Pg. 446-452
|
Nonsterile Basics of Compounding: Compounding with Antioxidants, Part 1: An Overview
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 295-302
|
PreScription: Amoxicillin Shortage Continues: Compounding Pharmacies Filling the Gap!
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 92
|
Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery
Rachmawati Putriana
|
Jan/Feb 2023
Pg. 24-29
|
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 30-37
|
Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 490-495
|
The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet
Alhmoud Hassan, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
|
Sep/Oct 2023
Pg. 431-439
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Mar/Apr 2024
Pg. 111-116
|
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
May/Jun 2021
Pg. 222-229
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 304-309
|
PreScription: The NASEM cBHT Report, Part 1
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 444
|
A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot
Brunner Scott
|
Jul/Aug 2021
Pg. 296-297
|
Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 41-49
|
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 118-126
|
Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website
Sluggett Janet K, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J
|
May/Jun 2019
Pg. 238-244
|
Standard Operating Procedure: Discarding of Broken Glass
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 153
|
Standard Operating Procedure: Complaint and Mishap Rectification
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 414-415
|
What Customers Want
Roberts Jerrod L
|
May/Jun 2005
Pg. 213-214
|
How'd They Do That?
Roberts Jerrod L
|
Jan/Feb 2006
Pg. 46-49
|
Marketing Your Prescription Compounding Practice: Part One
Letendre William R, Jackson Richard A
|
Jan/Feb 2000
Pg. 36-38
|
Profile of a Practice
Davis Jeanie Lerche
|
Jan/Feb 2000
Pg. 40-41
|
Marketing Your Prescription Compounding Practice: Part Two
Letendre William R, Jackson Richard A
|
Mar/Apr 2000
Pg. 115-117
|
Branding: Give Your Small Business a Big Image
Storey Patricia L
|
Nov/Dec 2008
Pg. 537-538
|
Inventory Information Approval System Certification and Flexible Spending Account Purchases: A New Year Brings Changes
Shuey Brandon, Williams LaVonn A
|
Mar/Apr 2010
Pg. 124-128
|
PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 4
|
PostScription: Pharmacists Advancing Toward Provider Status
Menighan Thomas E
|
Jan/Feb 2015
Pg. 86-87
|
Calculations
Stockton Shelly J
|
Jan/Feb 2015
Pg. 59
|
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions
Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
|
Jan/Feb 2015
Pg. 73-77
|
PostScription: The Future of Veterinary Compounding
Jordan Dinah G
|
Sep/Oct 2014
Pg. 438-439
|
Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date
Thomson Cassandra Marie, Savji Taslim
|
Nov/Dec 2014
Pg. 456-460
|
PreScription: 2014 in Review
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 4
|
Quality Control Analytical Methods: Refractive Index
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 43-47
|
Applying Quality of Design Concepts to Pharmacy Compounding
Timko Robert J
|
Nov/Dec 2015
Pg. 453-463
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream
Wang Xuexuan, Black Laura
|
Nov/Dec 2013
Pg. 520-525
|
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies
Brensel Robert, Brensel Scott, Ng Amy
|
Nov/Dec 2013
Pg. 465-475
|
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities
Miller David G
|
Mar/Apr 2014
Pg. 117-118
|
Sulfamethoxazole and Trimethoprim Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 415
|
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017
Pg. 66-75
|
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017
Pg. 76-82
|
The "Lists": What Do They Mean?
Voliva John
|
Nov/Dec 2016
Pg. 477-479
|
Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 485-493
|
More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard!
Voliva John
|
Sep/Oct 2016
Pg. 377-378
|
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John, Light Bob
|
May/Jun 2016
Pg. 250-256
|
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
|
Jul/Aug 2016
Pg. 328-332
|
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding
Miller David G
|
Sep/Oct 2015
Pg. 375
|
Cefepime Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 505
|
Cefotaxime 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 506
|
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 507
|
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States
Lobb William B, Wilkin Noel E, Holmes Erin R
|
Nov/Dec 2015
Pg. 514-520
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 509
|
Levetiracetam 100-mg/mL Injection (Concentrate)
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 510
|
PreScription: Compounding: A Changing Paradigm
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 92
|
Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
|
Mar/Apr 2016
Pg. 155-158
|
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
|
Mar/Apr 2016
Pg. 107-113
|
PreScription: Patient Access to Pharmaceuticals
Allen Loyd V Jr
|
May/Jun 2016
Pg. 180
|
Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
|
Jul/Aug 2016
Pg. 271-274
|
IACP's 2016 Compounders on Capitol Hill Asks
|
Jul/Aug 2016
Pg. 294-296
|
Patient Access Is a Patient Safety Issue
Pore David
|
Mar/Apr 2019
Pg. 120-121
|
Nimodipine Compounded Oral Suspension: A True Documented Medical Need
McElhiney Linda F
|
Mar/Apr 2019
Pg. 106-111
|
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding
Martin Matt
|
Jan/Feb 2019
Pg. 47-49
|
Current Trends and Emerging Priorities in Compounded Preparations for Children
Parrish Richard H II
|
Sep/Oct 2018
Pg. 358-366
|
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
|
Nov/Dec 2018
Pg. 516-526
|
PreScription: Standardized Concentrations: Pro or Con?
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 444
|
Basics of Compounding: Hot Melt Extrusion
DePasquale Seth
|
Nov/Dec 2017
Pg. 471-479
|
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Trimble John O, Light Bob
|
Nov/Dec 2017
Pg. 530-535
|
Pain: Systematic Review of Pharmacy Compounding of Pain Medication
Shawaqfeh Mohammad S, Harrington Catherine
|
Jan/Feb 2018
Pg. 19-24
|
The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives
Blankenship Cynthia
|
Jan/Feb 2018
Pg. 26-28
|
Basics of Compounding: Compounding Microemulsions
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 137-143
|
PreScription: Compounding Pharmacy Issues for 2017
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 4
|
The International Academy of Compounding Pharmacists Introduces a New President
Rice Baylor
|
Mar/Apr 2017
Pg. 116-117
|
Warfarin Personalized Dosage: Re-compounding for a More Suitable Therapy and Better Compliance
Pellagatti Tommaso, Ternelli Marco, Frascio Davide, Bettini Ruggero
|
May/Jun 2017
Pg. 247-250
|
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 444
|
IACP Legislative/Regulatory Update
International Academy of Compounding Pharmacists
|
Sep/Oct 2017
Pg. 382-383
|
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 356
|
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Greeson Nicole MH, Mixon William, Allan W Chris
|
Sep/Oct 2020
Pg. 371-379
|
Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 397-402
|
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 320
|
Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula
Hossain Mohammad Faisal, Levesque Dan, Frye John, Rashid Mamoon
|
Jul/Aug 2020
Pg. 322-326
|
Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested
Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson
|
Sep/Oct 2020
Pg. 408-412
|
PreScription: COVID-19 and Compounding Pharmacists
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 268
|
Quality Control: Photostability of Compounded Preparations
Allen Loyd V Jr
|
May/Jun 2020
Pg. 200-205
|
Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2020
Pg. 227
|
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Ngim Kenley, Patel Jalpa
|
May/Jun 2020
Pg. 242-245
|
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
|
Mar/Apr 2020
Pg. 168-175
|
Erratum: Kiselova O, Maurina B, Sidlovska V et al. Trends of Extemporaneous Drug Prescription in Latvia in 2017. IJPC 2019; 23(3): 245-249.
|
Jul/Aug 2019
Pg. 351
|
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
Vaughn Stacey R, Radwick Allison
|
Jan/Feb 2020
Pg. 14-19
|
Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future
Brunner Scott
|
Jul/Aug 2019
Pg. 294-296
|
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1
Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
|
Sep/Oct 2019
Pg. 387-391
|
Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control
Hutson Chad, Day A J
|
Nov/Dec 2019
Pg. 511-518
|
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2
Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
|
Nov/Dec 2019
Pg. 467-471
|
Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 472-477
|
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 245
|
The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy
Miller David G
|
Mar/Apr 2012
Pg. 94-96
View Sample |
Selection of Color Additives: A Regulatory View
Kumar Anuj, Dureja Harish, Madan Anil K
|
Jul/Aug 2012
Pg. 304-309
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 490-496
|
Pediatric Health Care: An Introduction
Williams LaVonn A
|
Jan/Feb 2013
Pg. 6-8
|
Optimizing Third-party Reimbursement for Compounded Medications
McElhiney Linda F
|
May/Jun 2013
Pg. 201-204
|
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 356
|
Compounding Pharmacies: Before and After an Inspection
Kulkarni Darshan, Ricketts Samantha
|
Sep/Oct 2013
Pg. 358-362
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David
|
Sep/Oct 2011
Pg. 382-384
|
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
|
May/Jun 2013
Pg. 247-253
|
PostScription: GMPs and GCPs: A Topical Comparison
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 87
|
Case Reports: Compounding to Relieve Arthritis Pain
Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
|
Nov/Dec 2008
Pg. 498-504
|
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Trissel Lawrence A
|
Nov/Dec 2008
Pg. 524-528
|
Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Jul/Aug 2008
Pg. 329-333
|
Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam
Veggeland Turid, Brandl Martin
|
Jan/Feb 2010
Pg. 78-81
|
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 56-61
|
In the Hands of Your Enemy
Worthen Dennis B
|
Nov/Dec 2010
Pg. 456-462
|
Sterile Compounding with Barrier-Isolation Technology
Rahe Hank
|
Jul/Aug 2001
Pg. 254-258
|
Stability of Nebulizer Admixtures
Blondino Frank E, Baker Matthew
|
Jul/Aug 2005
Pg. 323-326
|
Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer
Reed-Kane Dana
|
Mar/Apr 2005
Pg. 93-94
|
Treating Canine Hepatic Disease
Davidson Gigi S
|
May/Jun 2003
Pg. 188-191
|
NDC Numbers: A New Approach
Heckman H Edward
|
Sep/Oct 2003
Pg. 358-359
|
Is Veterinary Compounding Illegal Under Federal Law?
Gibbs Jeffrey N
|
Nov/Dec 2004
Pg. 449-450
|
PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk!
Mason Dave
|
May/Jun 2006
Pg. 240
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
May/Jun 2007
Pg. 220-225
|
Hormone Therapy: It's Time for a Second Opinion
Collins Joseph J, Ahlgrimm Maria
|
Mar/Apr 2008
Pg. 122-127
|
PreScription: First Estriol, Then What?
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 284
|
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
|
Jul/Aug 2008
Pg. 365-367
|
PostScription: It Is Not Just What You Say…But How You Say It!
Reed-Kane Dana
|
Jul/Aug 2008
Pg. 375
|
Litigating the Legality of Compounding: The Medical Center Pharmacy Case
Gibbs Jeffrey N
|
May/Jun 2008
Pg. 238-241
|
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Fields Shannon W
|
May/Jun 2007
Pg. 200
|
PreScription: Standing in the Gap
Allen Loyd V Jr
|
May/Jun 2022
Pg. 180
|
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
|
May/Jun 2022
Pg. 248-254
|
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 356
|
Compounding Robots for Intravenous Therapy in European Countries: A Review in 2020
Hecq Jean-Daniel, Soumoy Laura
|
Nov/Dec 2021
Pg. 510-514
|
Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets
Azmi Nurual Hanisah Saiful, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
|
Jan/Feb 2022
Pg. 80-87
|
Sterile Basics of Compounding: Contamination Control Strategies, Part 1
Summers Amy
|
Sep/Oct 2022
Pg. 411-418
|
Calculations
Stockton Shelly J
|
Sep/Oct 2022
Pg. 420
|
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies
Maham Nicole Y
|
Nov/Dec 2022
Pg. 474-479
|
Basics: Hollow-type Suppositories
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 302-307
|
Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program
Summers Amy
|
Jul/Aug 2022
Pg. 309-315
|
Calculations
Stockton Shelly J
|
Jul/Aug 2022
Pg. 316
|
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
|
Sep/Oct 2021
Pg. 372-377
|
It's Time for a New Philosophy
Brunner Scott
|
Sep/Oct 2021
Pg. 386-387
|
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Sep/Oct 2021
Pg. 389-395
|
Editorial: Should All Pharmacists Compound?
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 24-28
|
Everything Old is New Again
Brunner Scott
|
Jan/Feb 2022
Pg. 30-32
|
Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 34-38
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Riepl Mike
|
Nov/Dec 2021
Pg. 468-472
|
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 131-139
|
PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 92
|
Stability of Fagron's Phytobase Cream Compounded with Various Hormones
Wynn Tom, Taylor Sarah, Zander Clark
|
Mar/Apr 2021
Pg. 156-162
|
A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies
Hall Essence, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal
|
May/Jun 2021
Pg. 197-204
|
FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows
Brunner Scott
|
May/Jun 2021
Pg. 206-209
|
Heartworm-, Flea-, and Tick-associated Diseases in Dogs: A Review of Common Parasites and Drug Classes Prophylactic Against Them
Riepl Mike
|
May/Jun 2024
Pg. 188-193
|
Prophylaxis Against Heartworm Infection and Flea or Tick Infestation in Dogs: Single Agents and Combination-Drug Products
Riepl Mike
|
May/Jun 2024
Pg. 205-213
|
Crushability Analysis of Immediate-Release Oral Tablets and Capsules from the 2020-22 FDA Novel Drug Approvals
Saei Kamaladdin, Schweighardt Anne, Zhao Fang
|
Sep/Oct 2024
Pg. 364-372
|
Stability Assessment of Methadone Hydrochloride Oral Solution for Dispensing in Drug Addiction Centers: A Physicochemical and Microbiological Study
Saura Mª Antonia Meroño, Sabater Pablo Selvi, Piñera Mª Pilar Sánchez, Pascual Mª Dolores Huéscar, Pérez Carmen Candel, Sanz Elena Urbieta
|
Nov/Dec 2024
Pg. 515-519
|
Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 123-139
|
Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Biundo Bruce
|
Sep/Oct 2023
Pg. 358-360
|
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 397-409
|
Intravenous Physical Compatibility of Heparin Sodium and Furosemide
Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
|
Nov/Dec 2022
Pg. 522-526
|
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy, Williams LaVonn
|
Jul/Aug 2022
Pg. 293-296
|
Show Me the Science: A Perspective
Grzib Anthony
|
May/Jun 2023
Pg. 208-210
|
HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now?
Miller David G
|
Nov/Dec 2013
Pg. 480-481
|
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
McPherson Timothy B, Neumann William L, Kolling William M
|
Nov/Dec 2013
Pg. 508-511
|
Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 477-479
|
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
|
Jan/Feb 2014
Pg. 14-19
|
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Vu Nicole, Nguyen Devin, Kupiec Thomas C
|
Mar/Apr 2014
Pg. 123-130
|
Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding
Hyde Tiffany D
|
Jan/Feb 2014
Pg. 46-52
|
E-Prescribing Errors Identified in a Compounding Pharmacy: A Quality-improvement Project
Reed-Kane Dana, Kittell Katrina, Adkins Jacquelyn, Flocks Sarah, Nguyen Thu
|
Jan/Feb 2014
Pg. 83-86
|
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers
McCluskey Susan V, Sztajnkrycer Matthew D, Jenkins Donald A, Zietlow Scott P, Berns Kathleen S, Park Myung S
|
Sep/Oct 2014
Pg. 432-437
|
To Compound or Not to Compound: A Veterinary Transdermal Discussion
Eichstadt Lauren R, Davidson Gigi S
|
Sep/Oct 2014
Pg. 366-369
|
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation
Phan Ha, DeReese Annie, Day A J, Carvalho Maria
|
May/Jun 2014
Pg. 203-207
|
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Warner Meredith, Tuder Dmitry
|
May/Jun 2014
Pg. 182-188
|
Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams
Allen Loyd V Jr
|
May/Jun 2014
Pg. 228-230
|
Naproxen 25-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2014
Pg. 239
|
PreScription: Challenging Times
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 268
|
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Johnson Kain, Sully Andrew, Anthenat Bruce
|
Jul/Aug 2014
Pg. 270-276
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Jul/Aug 2014
Pg. 278-286
|
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India
Kumar Anuj, Madan Anil K
|
Jul/Aug 2014
Pg. 293-300
|
400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill
Miller David G
|
Jul/Aug 2014
Pg. 302
|
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Vu Nicole, Lou Jessica R, Kupiec Thomas C
|
Jul/Aug 2014
Pg. 305-310
|
Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 313-317
|
Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 325
|
Choline Magnesium Trisalicylate Liquid
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 327
|
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
|
Jul/Aug 2014
Pg. 332-340
|
PostScription: Responsibilities of a Compounding Pharmacist
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 351
|
Root Cause Analysis, Part 1: Nonsterile Compounding
Cabaleiro Joe, Jackson Kathleen
|
Nov/Dec 2015
Pg. 465-469
|
Basic Principles of Lyophilization, Part 1
Akers Michael J
|
Nov/Dec 2015
Pg. 471-476
|
Benzonatate 100-mg Capsules
Allen Loyd V
|
Jul/Aug 2015
Pg. 326
|
Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals
Meek Claudia, Rothardt Andrew, Evans Jason, Thurman Rosanne, Ashworth Lisa, Leff Richard
|
Jul/Aug 2015
Pg. 340-343
|
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes
Anderson Collin R, Halford Zachery, MacKay Mark
|
Jul/Aug 2015
Pg. 344-347
|
Quality Control Analytical Methods: Physical Quantitative Verification of Nonsterile Compounded Preparations: Individualized Dosage Units
Sidhu Raman
|
Jul/Aug 2015
Pg. 307-310
|
Stability of Metronidazole Suspensions
Donnelly Ronald F, Ying James
|
May/Jun 2015
Pg. 248-251
|
Protocol of Blood Serum Eye Drops
Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
|
May/Jun 2015
Pg. 252-260
|
PreScription: Potpourri of Opinions…From Many
Allen Loyd V
|
Jul/Aug 2015
Pg. 266
|
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Jul/Aug 2015
Pg. 268-278
|
Basics of Sterile Compounding: Aseptic Processing
Akers Michael J
|
Jan/Feb 2015
Pg. 49-56
|
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance
Grilli Anthony, Sutton Scott
|
Jan/Feb 2015
Pg. 30-37
|
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 38-40
|
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Akers Michael J
|
Nov/Dec 2014
Pg. 479-484
|
Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 486-488
|
New England Compounding Center Indictment
Cabaleiro Joe
|
Mar/Apr 2015
Pg. 94-102
|
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 148
|
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
|
May/Jun 2015
Pg. 195-203
|
Quality Assurance and Quality Control, Part 2
Akers Michael J
|
May/Jun 2015
Pg. 215-221
|
Basics of Compounding: Compounding Films
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 298-305
|
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding
Akers Michael J
|
Jul/Aug 2016
Pg. 307-314
|
Calculations
Stockton Shelly J
|
Jul/Aug 2016
Pg. 316-317
|
Current Perspectives on the Syringe Delivery System
Akers Michael J
|
May/Jun 2016
Pg. 182-186
|
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Sturn Kayla M, Collin Michael
|
May/Jun 2016
Pg. 197-201
|
Pain-Away II Headache Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 233
|
Basics of Compounding: Capsules
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 125-134
|
Formulation and Stability of Solutions
Akers Michael J
|
Mar/Apr 2016
Pg. 137-141
|
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
|
Mar/Apr 2016
Pg. 167-174
|
Root Cause Analysis, Part 2: Sterile Compounding
Cabaleiro Joe, Jackson Kathleen
|
Mar/Apr 2016
Pg. 99-104
|
Memantine Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 511
|
Mupirocin 2% Nasal Ointment
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 512
|
Propranolol Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 513
|
PostScription: The Home Field Advantage
Cabaleiro Joe
|
Jan/Feb 2016
Pg. 86-87
|
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 508
|
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
|
Nov/Dec 2015
Pg. 491-500
|
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 504
|
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
|
Jul/Aug 2016
Pg. 333-337
|
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump
Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
|
Jul/Aug 2016
Pg. 343-346
|
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Jul/Aug 2016
Pg. 347-350
|
PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing?
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 268
View Sample |
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
|
Sep/Oct 2016
Pg. 359-364
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
|
Nov/Dec 2016
Pg. 461-467
|
Inamrinone 5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 408
|
Naproxen 5% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 410
|
Sodium Phosphate Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 413
|
Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product
Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Sep/Oct 2016
Pg. 416-420
|
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light
Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael
|
Sep/Oct 2016
Pg. 435-437
|
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution
Tannous Elias, Tal Yana, Amarny Kamal
|
Sep/Oct 2016
Pg. 438-439
|
Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 509
|
PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution
Rost Erika
|
Nov/Dec 2016
Pg. 526-527
|
Introduction to Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 481-484
|
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
|
Jan/Feb 2017
Pg. 22-27
|
Analytic Methods Used in Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 31-37
|
Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules
Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
|
Mar/Apr 2017
Pg. 171-175
|
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Allen Loyd V Jr
|
May/Jun 2017
Pg. 180
|
Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats
Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
|
May/Jun 2017
Pg. 242-246
|
Accuracy Considerations in Sterile Compounding
Akers Michael J
|
Mar/Apr 2017
Pg. 133-142
|
Calculations
Stockton Shelly J
|
Mar/Apr 2017
Pg. 144
|
Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date
Gautam Pradeep, Light Bob, Purvis Troy
|
Mar/Apr 2017
Pg. 154-159
|
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 478-482
|
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 490
|
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki Ayah, Agu Remigius U
|
Nov/Dec 2019
Pg. 496-503
|
Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets
Mulder Kyle
|
Jan/Feb 2020
Pg. 7-12
|
Threading the Needle
Brunner Scott
|
Sep/Oct 2019
Pg. 383-385
|
Basics: Excipients Used in Nonsterile Compounding, Part 2
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 393-396
|
Long-term Physiochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics
Lardinois Benjamin, Baltzis Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
|
Sep/Oct 2019
Pg. 434-437
|
PreScription: As Things Change….
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 444
|
Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients
de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
|
Jul/Aug 2019
Pg. 324-331
|
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 38-43
|
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 121-126
|
Calculations
Stockton Shelly J
|
Mar/Apr 2020
Pg. 128
|
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit
Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence M
|
Jan/Feb 2020
Pg. 64-68
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
|
May/Jun 2020
Pg. 182-186
|
Feasibility Study of Asthma Cream
Kuang Andrew
|
Mar/Apr 2020
Pg. 163-167
|
Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days
Svirskis Darren, Jaffer Johaina, Agarwal Priyanka, Khan Ayeshah, Kaur Jaskarn, Cheng Alan, Hanning Sara
|
May/Jun 2020
Pg. 246-251
|
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Allen Loyd V Jr
|
May/Jun 2020
Pg. 215-220
|
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Greeson Nicole MH, Mixon William, Allan W Chris
|
Jul/Aug 2020
Pg. 270-276
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 278-281
|
Quality Control: Rapid Sterility Testing for Compounding Pharmacies
Taylor Andrew
|
Jul/Aug 2020
Pg. 299-303
|
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 305-309
|
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 313
|
Efficacy of an Automated Robotic Cleaning Device for Compounding Pharmacies
Polonini Hudson, Dijkers Eli CF, Ferreira Anderson O, da Silva Sharlene L, Araújo Paulo Victor C, Koulouridas Savvas
|
Sep/Oct 2020
Pg. 426-433
|
Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection
(Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection
(Vet-Mouse)
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 406
|
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 46
|
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
|
Jan/Feb 2021
Pg. 73-81
|
Experimental Multidisciplinary Approach Based on Compounded Capsule's Quality Evaluation for Pharmacy Undergraduate Courses
dos Santos Matheus Skrcek Ribeiro, de Lima Amanda Muniz dos Santos, Christoff Adriana de Oliveira, Teixeira Mariana Lopes, Carneiro Jaqueline
|
Mar/Apr 2021
Pg. 104-108
|
Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic
Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
|
Mar/Apr 2021
Pg. 109-113
|
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
|
Mar/Apr 2021
Pg. 115-124
|
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1
DeRosa Angela
|
Nov/Dec 2020
Pg. 466-470
|
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 473-478
|
Analysis of Extemporaneously Compounded Nasal Preparations Prescribed by Latvian Otorhinolaryngologists and General Practitioners and Comparison with German Formulations
Kiselova Olga, Maurina Baiba, Sidlovska Venta
|
Nov/Dec 2020
Pg. 491-500
|
Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure
Ma Nathan, Perks William, Law Shirley, Iazzetta John, Walker Scott
|
Nov/Dec 2020
Pg. 519-527
|
PreScription: The NASEM cBHT Report, Part 2
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 4
|
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2
DeRosa Angela
|
Jan/Feb 2021
Pg. 14-17
|
Quality Control: Bar Codes and Bar Code Scanners for Unit-Dose Medications in a Healthcare Setting
Medi-Dose Inc./EPS Inc.
|
Sep/Oct 2017
Pg. 384-387
|
Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 364-370
|
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags
Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
|
Sep/Oct 2017
Pg. 436-439
|
Change Is In the Air: What You Need to Know About Pharmacy Ventilation Under United States Pharmacopeia <800>
Laniewicz Cheryl
|
Jul/Aug 2017
Pg. 271-274
|
The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871
Rice Baylor
|
Jul/Aug 2017
Pg. 290-291
|
Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori
Mah Xian-Jun, Gupta Vikas, Loch Srey Neth, Ahlenstiel Golo, van de Poorten David
|
Jul/Aug 2017
Pg. 330-333
|
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia
Robert Julien, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine
|
Jul/Aug 2017
Pg. 347-351
|
Calculations
Stockton Shelly J
|
Mar/Apr 2018
Pg. 144
|
IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing
Blankenship Cynthia
|
Mar/Apr 2018
Pg. 125-126
|
Tolmetin 400-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 497
|
Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland
Suvikas-Peltonen Eeva, Palmgren Joni, Häggman Verner, Celikkayalar Ercan, Manninen Raija, Airaksinen Marja
|
Nov/Dec 2017
Pg. 518-529
|
Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort!
Blankenship Cynthia
|
Nov/Dec 2017
Pg. 468
|
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 54
|
Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing
Song Guiyun, Banov Daniel, Bassani August S
|
Jan/Feb 2018
Pg. 60-65
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection
Wu George, Powers Dan, Yeung Stanley, Chen Frank
|
Jan/Feb 2018
Pg. 76-85
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
|
Jan/Feb 2018
Pg. 86-94
|
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
|
Mar/Apr 2018
Pg. 172-175
|
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture
Allen Loyd V Jr
|
May/Jun 2018
Pg. 237
|
Trace Level Analysis of Airborne Hormone Particulates
Trimble John O, Hampton Shanna
|
May/Jun 2018
Pg. 257-263
|
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Martin Matt
|
Jul/Aug 2018
Pg. 303-312
|
Calculations
Stockton Shelly J
|
Jul/Aug 2018
Pg. 314
|
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
|
Jul/Aug 2018
Pg. 270-278
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 52
|
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 53
|
Orodispersible Film
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 59
|
PreScription: Compounding with Cannabidiol
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 92
|
Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia
Zur Eyal
|
Mar/Apr 2019
Pg. 113-119
|
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Williams LaVonn A
|
Jan/Feb 2019
Pg. 14-21
|
Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
|
Jan/Feb 2019
Pg. 23-31
|
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 123-130
|
Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 149
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 150
|
Rosuvastatin 20-mg/5-mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 152
|
Tacrolimus 0.5 mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 153
|
Can We Fix It?
Brunner Scott
|
May/Jun 2019
Pg. 208-209
|
Levorphanol for the Treatment of Severe Chronic Pain
McNulty Jack P
|
May/Jun 2007
Pg. 202-211
|
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2007
Pg. 404-410
|
The Whales: A Pharmacist's Story
Wills William R
|
Sep/Oct 2007
Pg. 376-383
|
Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds
Trusley Craig
|
Nov/Dec 2007
Pg. 487-490
|
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Nov/Dec 2007
Pg. 520-524
|
Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration
Dib Jean G, Abdulmohsin Saud
|
Jan/Feb 2008
Pg. 8-14
|
Diclofenac Sodium 1% Soft-Patch Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 65
|
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 66
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2008
Pg. 54-60
|
Piroxicam 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 71
|
Piroxicam 1% Soft-Patch Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 72
|
A Process Verification Model for Quality Assurance in a Compounding Pharmacy
Zolner William J
|
May/Jun 2008
Pg. 247-251
|
Establishing a Quality-Assurance Program for Hospital Compounding
McElhiney Linda F
|
Mar/Apr 2008
Pg. 116-120
|
Estriol: Women's Choice vs. A Manufacturer's Greed
Goodrum Jennifer
|
Jul/Aug 2008
Pg. 286-292
|
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 156-160
|
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 170-173
|
Meloxicam 0.3% Topical Gel
Allen Loyd V Jr
|
May/Jun 2008
Pg. 264
|
PreScription: Pain!
Allen Loyd V Jr
|
May/Jun 2008
Pg. 180
|
Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 416
|
Diclofenac Sodium 75-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 421
|
Room Temperature Stability of Injectable Succinylcholine Dichloride
Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
|
Jan/Feb 2008
Pg. 83-85
|
Transdermal Gel in the Treatment of Postoperative Pain
Alexander Kayla, Wynn Tom
|
May/Jun 2007
Pg. 181-184
|
Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis
Fields Shannon W
|
Jan/Feb 2007
Pg. 26-27
|
PostScription: IJPC—More Than a Journal
|
Jan/Feb 2007
Pg. 88
|
Book Review: The Rexall Story: A History of Genius and Neglect
Grajeda Betty Jo
|
Jul/Aug 2007
Pg. 300
|
The Politics of Hormone Replacement Therapy
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 278-281
|
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Okeke Claudia C
|
Jul/Aug 2007
Pg. 302-305
|
Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard)
Benischek Rita L, Riffell Gregory S, Mauldin Todd
|
Nov/Dec 2006
Pg. 426-427
|
Information Resources and Software for the Hospital Compounding Pharmacist
McElhiney Linda F
|
Jan/Feb 2007
Pg. 36-41
|
Innovations in Compounding: Integrated Barcode System Verifies Chemical Identity, Weight
Vail Jane
|
Jul/Aug 2006
Pg. 291-292
|
Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches
Williams Steve D
|
Sep/Oct 2006
Pg. 351
|
Chemical Stability of Diclofenac Sodium Injection
Gupta Vishnu D
|
Mar/Apr 2006
Pg. 154-155
|
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle
Benischek Rita L
|
Nov/Dec 2006
Pg. 428-433
|
Ronidazole in the Treatment of Trichomonad Infections in Cats
Davidson Gigi S
|
Nov/Dec 2006
Pg. 434-435
|
Indomethacin 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 458
|
Naltrexone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 459
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration
Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
|
May/Jun 2006
Pg. 234-236
|
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together
Gupta Vishnu D
|
May/Jun 2006
Pg. 237-239
|
Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
|
May/Jun 2003
Pg. 170-174
|
The Future of Compounding: An Industry Perspective
Capps Shelly, Winckler Susan C, Anthony Calvin J, Halperin Jerome A
|
May/Jun 2000
Pg. 204-205
|
PostScription: Experts Everywhere
Rahe Hank
|
Mar/Apr 2005
Pg. 167
|
Update on Transdermals for Animal Patients
Davidson Gigi S
|
May/Jun 2005
Pg. 178-182
View Sample |
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery
Heim Bob
|
Jan/Feb 2006
Pg. 14-18
View Sample |
Pharmaceutical Legislation: An Historical Perspective
Worthen Dennis B
|
Jan/Feb 2006
Pg. 20-28
|
Pharmacy Compounding Urban Legends
Kastango Eric S
|
Jan/Feb 2006
Pg. 32-34
|
Basics of Compounding for Skin Discolorations
Allen Loyd V Jr
|
Sep/Oct 2004
Pg. 376-380
|
Naproxen Sodium 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 68
|
Standard Operating Procedure for Quality Assessment of Special Hard-Gelatin Capsules
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 312-313
|
Book Reviews: Stability and Formulation References
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 25
|
Extemporaneous Formulations in Pediatric Patients
Nahata Milap C
|
Jul/Aug 1999
Pg. 274-276
|
The BPS Pharmacy Specialty Certification Program
Bertin Richard J
|
May/Jun 1999
Pg. 200-203
|
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Rice Stephen P
|
Mar/Apr 2002
Pg. 120-122
|
Flavors and Flavoring
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 90-92
|
Natural Testosterone: Hormone of the Heart
Wright Jonathan V, Lenard Lane
|
Mar/Apr 1999
Pg. 88-98
|
Standard Operating Procedure for Quality Assessment of Oral and Topical Liquids
Allen Loyd V Jr
|
Mar/Apr 1999
Pg. 146-147
|
Complications of Diabetes
Key David M
|
Mar/Apr 2000
Pg. 88-90
|
"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care
Cox Chris
|
Nov/Dec 2010
Pg. 480-483
|
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 520
|
Goliath: Case Report on a Canine Case of Epilepsy
Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
|
Jan/Feb 2011
Pg. 27-31
|
Toxicities Associated with Topical Anesthetics
Bramwell Bethany L
|
Jan/Feb 2011
Pg. 41
|
Marketing Vitamins, Minerals, and Other Nutrients
Kress Robert B
|
Jan/Feb 2011
Pg. 44-47
|
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 512
|
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 513
|
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 514
|
Ketoprofen 2% Oral Gel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 521
|
Diclofenac Sodium 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 64
|
Ibuprofen 5% Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 66
|
Piroxicam 1% Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 69
|
Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 71
|
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs
Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei
|
Jan/Feb 2011
Pg. 74-77
|
The Relevance of the Soviet Pharmaceutical Industry and Dispensing: Dependence on Traditional Compounding
Conroy Mary Schaeffer
|
Mar/Apr 2011
Pg. 117-122
|
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 157
|
PostScription: Commentary: Discussion on the Safety of Topical Prilocaine
Bramwell Bethany L
|
Mar/Apr 2011
Pg. 174-175
|
Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?
Williams LaVonn A
|
Mar/Apr 2010
Pg. 105-107
|
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Okeke Claudia C, Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 328-331
|
Flurbiprofen 5% Bioadhesive Gel for Gingivitis
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 341
|
Ketoprofen 100-mg/5-mL Mouth Rinse
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 68
|
Trigger Point Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 75
|
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 74
|
PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort?
Allen Loyd V Jr, Burger Mark
|
Mar/Apr 2010
Pg. 174-175
|
PreScription: Healthcare Reform Is Not All That Is Happening in Washington
Menighan Thomas E
|
May/Jun 2010
Pg. 180
|
Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
|
May/Jun 2010
Pg. 200-203
|
Managing Pain with Transdermal Ketoprofen
Williams KaCee D
|
May/Jun 2010
Pg. 204-206
|
Carprofen 2.5-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
|
May/Jun 2010
Pg. 241
|
Celecoxib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 242
|
Quality Control Analytical Methods: Continuous Quality Improvement
Odegard Russell D
|
May/Jun 2010
Pg. 218-221
|
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
McElhiney Linda F
|
Jul/Aug 2010
Pg. 270-274
|
Recommendations for Compounding Medications for Feeding Tube Administration
Klang Mark
|
Jul/Aug 2010
Pg. 276-282
|
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser
Christiansen Joel, White Lyndell
|
Jul/Aug 2010
Pg. 310-314
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Jul/Aug 2008
Pg. 368-371
|
Chemical Stability of Scopolamine Hydrobromide Nasal Solution
Gupta Vishnu D
|
Sep/Oct 2009
Pg. 438-439
|
Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study
Haywood Alison, Bolitho Richard, Gusti Kane, Yim Crystal, Testa Chris, Hattingh Laetitia
|
Sep/Oct 2009
Pg. 440-444
|
A Review of Stomatitis and Treatment in Cats
Ray Jody D, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E
|
Sep/Oct 2009
Pg. 372-381
|
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A, Fokken Dawn
|
Sep/Oct 2009
Pg. 386-389
|
An Abridged History of Aspirin
Vance Dwight A
|
Sep/Oct 2009
Pg. 404-409
|
Compounding for Cancer in Companion Animals
Mixon William, Northrup Nicole, Vail Jane
|
Jan/Feb 2009
Pg. 42-49
|
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration
Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel
|
Jan/Feb 2009
Pg. 78-80
|
Formulation Optimization Study for an Immediate-Release Tablet
Kyriacos Soula, Dimassi Hani
|
May/Jun 2009
Pg. 259-261
|
Update on Managing Neuropathic Pain
McNulty Jack P, Muller George
|
May/Jun 2009
Pg. 182-190
|
Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G, Pepin Steven M
|
May/Jun 2009
Pg. 218-219
|
Indomethacin 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 543
|
Ketorolac Tromethamine 2% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 544
|
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 540
|
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 541
|
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration
Shields David E, Aclan Jennifer, Szatkowski Aaron
|
Nov/Dec 2008
Pg. 553-557
|
Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William, Angelle Patricea, Yoch Douglas
|
Jan/Feb 2009
Pg. 6-12
|
Aceclofenac 1.5% Gel-Cream
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 446
|
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration
Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
|
Sep/Oct 2008
Pg. 460-462
|
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Shields David E, Aclan Jennifer, Szatkowski Aaron
|
Sep/Oct 2008
Pg. 463-466
|
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Sep/Oct 2008
Pg. 414-418
|
Excipient Choices for Special Populations
Nagel-Edwards Karen M, Ko James Y
|
Sep/Oct 2008
Pg. 426-430
|
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations
Cabaleiro Joe
|
Sep/Oct 2008
Pg. 432-433
|
Ketoprofen 20% Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 452
|
Piroxicam 5% and Dexpanthenol 5% Gel
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 454
|
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists
Macklin Denise, Blackburn Paul L
|
Mar/Apr 2013
Pg. 100-110
|
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program
Griffiths Tricia, Connors Anne
|
Mar/Apr 2013
Pg. 130-134
|
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
Mar/Apr 2013
Pg. 168-174
|
Decontamination Technology: The Missing Element
Rahe Hank
|
May/Jun 2013
Pg. 193-199
|
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms
McElhiney Linda F
|
Sep/Oct 2013
Pg. 364-368
|
Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 419
|
Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration
Ramaley Corrine C, Li Feng, Du Chengan
|
Sep/Oct 2013
Pg. 436-438
|
Considerations for Pharmacists Working in Major Disaster Areas
Kawataba Yoshinori
|
Nov/Dec 2013
Pg. 459-463
|
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial
Williams LaVonn A
|
May/Jun 2013
Pg. 262-263
|
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A, Stout Richard R, Ron Marcinkoski
|
Jul/Aug 2013
Pg. 270-280
|
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations
Allen Loyd V Jr
|
May/Jun 2013
Pg. 210-219
|
Buffered Aspirin Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 228
|
Calcium Acetate 667-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 229
|
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 230
|
Ethambutol 400-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 231
|
Isoniazid 300-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 232
|
Labetalol 50-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 233
|
Mercaptopurine 75-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 234
|
Naltrexone Hydrochloride 50-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 235
|
Prednisone 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 236
|
Reserpine 0.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 237
|
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Zur Eyal
|
Jan/Feb 2013
Pg. 10-22
|
Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 67
|
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
|
Jan/Feb 2013
Pg. 74-85
View Sample |
Beyond-use Date: Establishment and Maintenance
Osteen Richard
|
Nov/Dec 2012
Pg. 471-474
|
Ketorolac Tromethamine 15-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 337
|
A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A, Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 270-274
|
Medical Therapy for Acquired Urinary Incontinence in Dogs
Hill Katie, Jordan Dinah, Ray Jody, Mays Andrew A, Griffin Katie
|
Sep/Oct 2012
Pg. 369-375
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David G
|
Sep/Oct 2012
Pg. 382-384
|
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Zur Eyal
|
Sep/Oct 2012
Pg. 386-393
|
Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes
Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, do Carmo Garcez Maria
|
Mar/Apr 2012
Pg. 98-102
|
A Concise Discussion of Headache Types, Part 1
Williams LaVonn A
|
Mar/Apr 2012
Pg. 125-132
|
PreScription: Working in Handcuffs
Menighan Thomas E
|
May/Jun 2012
Pg. 180
|
Compounding and Dispensing Errors Before and After Implementing Barcode Technology in a Nuclear Pharmacy
Galbraith Wendy, Shadid Jill
|
May/Jun 2012
Pg. 253-256
|
Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant
Jha Antesh Kr, Chetia D
|
Nov/Dec 2011
Pg. 521-525
|
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration
Zhang Yang, Scarlett Cameron, Hutson Paul
|
Jan/Feb 2012
Pg. 82-85
|
Institute for Safe Medication Practices Lifetime Achievement Award 2011
Trissel Lawrence A
|
Jan/Feb 2012
Pg. 54-56
|
PreScription: Third-party Inequities and Discrimination
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 356
|
PreScription: American Pharmacists Month: A Time for Taking Responsibility
Menighan Thomas E
|
Sep/Oct 2011
Pg. 356
|
PostScription: Compounders Go Above and Beyond in the Name of Safety
Gates Ernest P Jr
|
Sep/Oct 2011
Pg. 438-439
|
PreScription: Compounding: Keeping Elephants Our of Our Mouseholes
Menighan Thomas E
|
Nov/Dec 2011
Pg. 444
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David G
|
Nov/Dec 2011
Pg. 471-472
View Sample |
The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire
Miller David G
|
Nov/Dec 2011
Pg. 474-479
View Sample |
Basics of Compounding: Basics of Compounding with Complex Organic Molecules
Allen Loyd V Jr
|
May/Jun 2011
Pg. 234-238
|
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 242
|
Diclofenac Sodium 1% Topical Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 243
|
Ibuprofen 5% Topical Cream
Allen Loyd V Jr
|
May/Jun 2011
Pg. 244
|
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate
Hergert Lisandro Y, Sperandeo Norma R, Allemandi Daniel A, Mazzieri Maria R
|
Jul/Aug 2011
Pg. 344-349
|
PreScription: Two Lessons in 17-Hydroxyprogesterone
Menighan Thomas E
|
Jul/Aug 2011
Pg. 268
|
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
|
Jul/Aug 2011
Pg. 290-300
|
Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 305-313
|
Calculations
Stockton Shelly J
|
Jul/Aug 2023
Pg. 314
|
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
|
Mar/Apr 2023
Pg. 108-112
|
Comparison of Three Reconstitution Devices: A Simulated Time and Use Study
Penoyer Daleen, Giuliano Karen, Middleton Aurea
|
Mar/Apr 2023
Pg. 169-174
|
Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
|
Jan/Feb 2023
Pg. 72-77
|
Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications
Dharmian Jose Prakash, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram
|
Nov/Dec 2023
Pg. 494-502
|
Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics
Rofiq Hanifah Mohd, Phang Hiu Ching, Janakiraman Ashok Kumar, Chew Yik-Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
|
Nov/Dec 2023
Pg. 512-521
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Mar/Apr 2024
Pg. 100-109
|
Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G, Pepin Steven M
|
Mar/Apr 2024
Pg. 118-119
|
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 130
|
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 131
|
Diclofenac Sodium 1% Soft-patch Gel
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 134
|
Considerations in Qualifying Critical Suppliers
Summers Amy
|
Nov/Dec 2023
Pg. 461-466
|
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
McKettrick Greg, Yoch Doug
|
Mar/Apr 2021
Pg. 94-98
|
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 311-317
|
Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
|
Jul/Aug 2021
Pg. 336-343
|
Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases
Teimouri Arezou, Yeung Pollen, Agu Remigius U
|
Jul/Aug 2021
Pg. 344-351
|
In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester
McKinney Rachael D, Dunbar Jacob R
|
May/Jun 2021
Pg. 241-245
|
Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists
Kiselova Olga, Maurina Baiba, Sidlovska Venta
|
Jul/Aug 2021
Pg. 288-295
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 491-496
|
Calculations
Stockton Shelly J
|
Nov/Dec 2021
Pg. 498
|
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 505
|
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Jul/Aug 2021
Pg. 298-302
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 403-408
|
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli
|
Sep/Oct 2021
Pg. 422-426
|
Indomethacin 1% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 325-326
|
PreScription: A New Dosage Form
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 356
|
Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules
de Oliveira Ferreira Anderson, Polonini Hudson
|
Jul/Aug 2022
Pg. 283-291
|
Recent Formulation Advances and Preparation of Orally Disintegrating Tablets
Ejeta Fikadu
|
Sep/Oct 2022
Pg. 370-377
|
The FDA is in a Hole. It Should Stop Digging.
Brunner Scott
|
Sep/Oct 2022
Pg. 396-398
|
Cysteamine Hydrochloride 100 mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 427
|
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 430
|
Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 55
|
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
|
May/Jun 2022
Pg. 219-228
|
Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate
Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
|
Mar/Apr 2022
Pg. 155-162
|
Molding as Innovative Technology for Personalized Tablet Production
Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
|
Mar/Apr 2022
Pg. 163-174
|
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2
Martin Matt
|
Nov/Dec 2018
Pg. 475-478
|
Pharmacogenomics: The End of Trial-and-Error Medicine?
Vail Jane
|
Jan/Feb 2007
Pg. 59-65
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
Jan/Feb 2007
Pg. 5-8
|
| Return to Top |
